DABUR - Dabur India
📢 Recent Corporate Announcements
Dabur India Limited has announced a transition in its senior management team. Ms. Isha Lamba, Head of Investor Relations & M&A, will step down effective May 1, 2026, following her resignation submitted in February. To fill the vacancy, the board has appointed Mr. Rahul Sarawagi as Additional General Manager - IR & M&A effective April 28, 2026. Mr. Sarawagi is a Chartered Accountant with over 18 years of experience and previously served as the Head of Treasury at Dabur.
- Ms. Isha Lamba to cease her role as Head-Investor Relations & M&A on May 1, 2026
- Mr. Rahul Sarawagi appointed as Additional General Manager - IR & M&A effective April 28, 2026
- Incoming executive Mr. Sarawagi brings 18+ years of experience from organizations including Goldman Sachs and Reliance Industries
- Transition includes a brief overlap period to ensure a smooth handover of IR and M&A responsibilities
Dabur India Limited has announced a transition in its senior management team for Investor Relations and M&A. Ms. Isha Lamba will step down from her role as Head of IR & M&A effective May 1, 2026. To fill the vacancy, the company has appointed Mr. Rahul Sarawagi as Additional General Manager - IR & M&A starting April 28, 2026. Mr. Sarawagi is a seasoned professional with over 18 years of experience in finance, including previous leadership roles at Dabur, Goldman Sachs, and Reliance Industries.
- Ms. Isha Lamba to resign as Head-Investor Relations & M&A effective May 1, 2026.
- Mr. Rahul Sarawagi appointed as Additional General Manager - IR & M&A effective April 28, 2026.
- Incoming appointee Mr. Sarawagi brings 18+ years of experience from firms including PwC, Goldman Sachs, and ICICI Bank.
- Mr. Sarawagi previously served as Head of Treasury at Dabur and most recently as CFO at Ace International Ltd.
Dabur India Limited has announced a transition in its senior management team for Investor Relations and M&A functions. Mr. Rahul Sarawagi, a Chartered Accountant with over 18 years of experience, has been appointed as Additional General Manager - IR & M&A effective April 28, 2026. This follows the resignation of Ms. Isha Lamba, the current Head of IR & M&A, who will be relieved on May 1, 2026. Mr. Sarawagi returns to Dabur after serving as CFO at Ace International Ltd and previously holding the Head of Treasury role at Dabur.
- Appointment of Mr. Rahul Sarawagi as Additional General Manager - IR & M&A effective April 28, 2026
- Resignation of Ms. Isha Lamba, Head-Investor Relations & M&A, effective May 1, 2026
- Mr. Sarawagi brings 18+ years of experience from organizations including Goldman Sachs, Reliance Industries, and ICICI Bank
- The new appointee previously served as Head of Treasury at Dabur India, ensuring internal familiarity
Dabur India Limited has officially confirmed the appointment of Mr. Herjit S. Bhalla as the Chief Executive Officer for its India Business, effective from April 23, 2026. This appointment follows a previous management update disclosed on February 17, 2026, and places Mr. Bhalla in a key Senior Management Personnel role. He will report directly to Mr. Mohit Malhotra, the Whole-time Director and Global CEO of the company. This move is intended to streamline leadership within Dabur's largest and most critical market segment.
- Mr. Herjit S. Bhalla joined as CEO - India Business on April 23, 2026.
- The appointment follows a prior management change disclosure dated February 17, 2026.
- Mr. Bhalla will report to Global CEO Mr. Mohit Malhotra.
- The role is classified under the Senior Management Personnel category of the company.
Dabur India Limited has announced its investor conference call to discuss the financial results for the quarter and full year ended March 31, 2026. The call is scheduled for May 7, 2026, at 5:00 PM IST, following the official declaration of the Q4 FY26 results. Management will provide insights into the company's performance, operational metrics, and future guidance during this session. Investors can access the call via Diamond Pass registration or a one-way audio webcast on the company's website.
- Earnings conference call scheduled for May 7, 2026, at 5:00 PM IST.
- The call will cover financial performance for the quarter and fiscal year ended March 31, 2026.
- Universal dial-in numbers provided: +91 22 6280 1110 and +91 22 7115 8011.
- International toll-free access available for major markets including USA (18667462133) and UK (08081011573).
Dabur India Limited has been informed of a penalty of INR 4,00,000 imposed by the Additional District Magistrate, Almora. The penalty relates to alleged contraventions of Sections 26 and 27 of the Food Safety and Standards Act, 2006, specifically concerning the labelling of one of its products. The company has stated that it intends to file an appeal before the 1st Appellate Authority, believing the demand is not maintainable. Dabur expects no material impact on its financial or operational activities from this order.
- Penalty of INR 4,00,000 imposed by the Addl. District Magistrate, Almora on April 10, 2026.
- Alleged violation of Sections 26 and 27 of the FSSAI Act regarding product labelling.
- Company intends to file an appeal with the 1st Appellate Authority.
- Management confirms no significant impact on financial or operational activities.
Dabur India Limited has filed its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations, 2018, for the period ending March 31, 2026. The certificate, provided by KFin Technologies Limited, confirms that all dematerialization requests were processed within the required 15-day window. It also verifies that physical share certificates were mutilated and cancelled after verification. This filing is a standard administrative procedure to ensure the accuracy of the company's shareholding records.
- Compliance certificate covers the period from January 1, 2026, to March 31, 2026.
- KFin Technologies Limited confirmed processing of demat requests within 15 days.
- Physical certificates were mutilated and cancelled post-verification as per SEBI norms.
- Depositories' names updated in the register of members for all approved requests.
Dabur's Q4 FY26 update indicates steady domestic momentum with high-single digit growth in the India FMCG business, though international performance was tempered by Middle East tensions. The Home & Personal Care segment is a standout, expected to grow in the mid-teens, while the Healthcare and F&B verticals faced headwinds from unseasonal rains, resulting in low-single digit growth. Consolidated revenues are projected to grow in the mid-single digits, with operating profits expected to outpace revenue growth, suggesting margin improvement. The company continues to gain market share across key categories like Juices and Hair Oils despite macroeconomic and geopolitical challenges.
- India FMCG business expected to record high-single digit growth with HPC segment growing in mid-teens.
- Hair Oils, Shampoo, and Home Care categories likely to record growth in the 20% range.
- Consolidated operating profit expected to grow ahead of the mid-single digit topline growth, indicating margin expansion.
- International business impacted by Middle East conflict, resulting in low-single digit growth in INR terms despite double-digit CC growth in other markets.
- Foods, Real Activ Juices, and Coconut Water maintained strong momentum with 20%+ growth rates.
Dabur India Limited is moving forward with the amalgamation of Sesa Care Private Limited, a process initiated in May 2025. Following a National Company Law Tribunal (NCLT) order dated March 12, 2026, the company has scheduled a meeting for its unsecured creditors on May 02, 2026. This meeting is a critical regulatory step to obtain approval for the Scheme of Amalgamation. Investors should note that this merger aims to consolidate Dabur's position in the Ayurvedic hair care segment by integrating the Sesa brand.
- NCLT New Delhi Bench issued directions on March 12, 2026, to convene a meeting of unsecured creditors.
- The meeting is scheduled for May 02, 2026, at 01:00 P.M. IST via video conferencing.
- The scheme involves the merger of Sesa Care Private Limited (Transferor) into Dabur India Limited (Transferee).
- This follows a series of regulatory updates regarding the merger dating back to May 26, 2025.
- Unsecured creditors will vote on the proposed scheme as per Sections 230 to 232 of the Companies Act, 2013.
Dabur India Limited has scheduled a court-convened meeting of its equity shareholders on May 2, 2026, following directions from the NCLT New Delhi Bench. The primary objective is to seek shareholder approval for the Scheme of Amalgamation between Sesa Care Private Limited and Dabur India. This procedural step follows the initial merger announcement made in May 2025 and subsequent updates. Shareholders will be able to vote on the proposal through remote e-voting or during the virtual meeting.
- Shareholders meeting scheduled for May 02, 2026, at 11:00 AM IST via Video Conferencing.
- The meeting is convened as per the NCLT order dated March 12, 2026, under Sections 230-232 of the Companies Act.
- The merger involves Sesa Care Private Limited as the Transferor Company and Dabur India as the Transferee Company.
- Notice and explanatory statements are being dispatched to shareholders via electronic and physical modes.
- This amalgamation process has been in progress since the initial board approval on May 26, 2025.
Dabur India Limited has informed the stock exchanges that its trading window for dealing in company securities will be closed for designated persons. The closure period is scheduled from April 1, 2026, to May 9, 2026, inclusive. This is a standard regulatory requirement under SEBI (Prohibition of Insider Trading) Regulations, 2015. The closure typically precedes the announcement of the company's financial results for the quarter and financial year ending March 31, 2026.
- Trading window closure effective from Wednesday, April 01, 2026.
- The window will remain closed until Saturday, May 09, 2026.
- Complies with SEBI (Prohibition of Insider Trading) Regulations, 2015.
- Closure period covers 39 days ahead of the expected Q4 and annual results announcement.
Dabur India has received directions from the NCLT to convene meetings of its equity shareholders and unsecured creditors regarding the merger with Sesa Care Private Limited. Sesa Care is a prominent player in the Ayurvedic hair oil segment with a paid-up capital of ₹966.50 crore. The merger, with an appointed date of April 1, 2026, aims to consolidate Dabur's market leadership by integrating Sesa's premium brand portfolio. This strategic move is expected to drive cost optimizations and distribution synergies across domestic and international markets.
- NCLT order dated March 12, 2026, directs Dabur to hold meetings for shareholders and unsecured creditors.
- Sesa Care holds the 3rd position in the Ayurvedic hair oil category, filling a strategic gap in Dabur's portfolio.
- The paid-up share capital of Sesa Care is ₹966.50 crore compared to Dabur's ₹177.37 crore.
- The scheme sets April 1, 2026, as the appointed date for the amalgamation.
- Synergies are expected through combined financial, technical, and distribution resources.
ICRA Limited has reaffirmed the highest credit ratings for Dabur India Limited's debt instruments and bank facilities. The company's Rs 250 crore Non-Convertible Debentures (NCD) programme maintained its [ICRA]AAA (Stable) rating. Additionally, bank facilities totaling Rs 1,000 crore were reaffirmed at [ICRA]AAA (Stable) and [ICRA]A1+. This reaffirmation underscores Dabur's strong financial profile and high degree of safety regarding timely servicing of financial obligations.
- ICRA reaffirmed [ICRA]AAA (Stable) rating for Rs 250 crore Non-Convertible Debentures.
- Total bank facilities of Rs 1,000 crore reaffirmed at [ICRA]AAA (Stable) and [ICRA]A1+.
- Bank limits include fund-based facilities from HDFC Bank (Rs 145 cr) and Standard Chartered (Rs 200 cr).
- Short-term interchangeable bank limits of Rs 175 crore reaffirmed at [ICRA]A1+.
Dabur India has announced its first investment through its 'Dabur Ventures' platform, acquiring a minority stake in luxury skincare D2C brand RAS Beauty for approximately Rs 60 Crore. RAS Beauty is a high-growth, digital-first company reporting a 3-year CAGR of 75% and an Annual Recurring Revenue (ARR) of nearly Rs 100 Crore. This strategic move marks Dabur's entry into the premium beauty segment, leveraging the target's high gross margins and 'Farm-to-Face' positioning. The investment will be used to scale RAS Beauty's omnichannel presence and R&D capabilities.
- Investment of Rs 60 Crore for a minority stake in luxury skincare brand RAS Beauty
- RAS Beauty demonstrates strong growth with a 3-year CAGR of 75% and ARR of ~Rs 100 Crore
- First deployment from the Rs 500 Crore Dabur Ventures fund launched in October 2025
- Target company operates in the high-margin premium D2C segment with in-house R&D and manufacturing
Dabur India Limited has successfully appealed against a tax demand totaling ₹3,12,74,277 issued by the State Tax authorities in Alwar, Rajasthan. The dispute, which involved product classification issues for the financial years 2017-18, 2018-19, and 2019-20, has been resolved in the company's favor. The 1st Appellate Authority has set aside the entire demand, including tax, interest, and penalties. The company has confirmed that this resolution will have no impact on its ongoing operations or financial activities.
- Appellate Authority set aside a total tax demand of ₹3,12,74,277.
- The demand included ₹97,28,014 in tax, ₹1,18,18,249 in interest, and ₹97,28,014 in penalty.
- Dispute related to product classification for FY 2017-18, 2018-19, and 2019-20.
- The favorable order was received by the company on February 26, 2026.
- Company confirms zero impact on business operations following this legal victory.
Financial Performance
Revenue Growth by Segment
Consolidated revenue grew 1.3% YoY to INR 12,563 Cr in FY25. Home & Personal Care (HP&C) constitutes ~35% of revenue; International business contributes 26.1% and grew 7.5% YoY in FY25. In FY24, HP&C grew 8% while Foods & Beverages (F&B) remained stable despite double-digit growth in the foods sub-segment due to weak beverage performance.
Geographic Revenue Split
Domestic India business accounts for ~74-75% of revenue. International business contributes ~25-26% of overall revenue, with high double-digit growth witnessed in the Middle East during FY24.
Profitability Margins
Gross margin stood at 47.6% in FY25. Operating margin was 18.6% in FY25, down from 19.5% in FY24 due to lower cost absorption and higher operational spending. 9M FY25 operating margin recovered to 19.4%. PAT margin was 13.9% in FY25 compared to 14.6% in FY24.
EBITDA Margin
Operating margin (OPBDIT/OI) was 19.4% for 9M FY25, remaining steady YoY. FY24 margin was 19.4% compared to 18.8% in FY23, an improvement of 60 basis points driven by moderating input cost inflation.
Capital Expenditure
Annual maintenance capex is projected at INR 300-500 Cr. A specific greenfield plant in Tamil Nadu is being set up at a cost of INR 400 Cr to be incurred over 5 years, funded entirely through internal accruals.
Credit Rating & Borrowing
CRISIL AAA/Stable and CRISIL A1+ ratings maintained. Interest coverage ratio was 20.51 times in FY25, down from 33.60 times in FY24. Total debt to OPBDIT stood at 0.6 times in FY24.
Operational Drivers
Raw Materials
Key raw materials include agricultural commodities and packaging materials; specific names not listed, but they faced 8% inflation in H1 FY25 which was offset by a 5% price increase and INR 60 Cr in saving initiatives.
Import Sources
Sourced globally and domestically to support 14 manufacturing units in India and 8 overseas units in UAE, Sri Lanka, South Africa, Nepal, Egypt, Bangladesh, Turkey, and Nigeria.
Capacity Expansion
Current manufacturing footprint includes 22 locations globally. Expansion includes a new multi-category plant in Tamil Nadu (INR 400 Cr investment) to enhance penetration in South India.
Raw Material Costs
Raw material prices declined in FY24 leading to margin expansion to 19.5%, but inflation returned in FY25. The company uses saving initiatives (INR 60 Cr in H1) to mitigate cost spikes.
Manufacturing Efficiency
Operating efficiency is maintained through a 'Power Brand' focus and a distribution network of 7.7 million retail outlets. Saving initiatives of INR 60 Cr targeted for the current fiscal.
Logistics & Distribution
Distribution network covers 7.7 million retail outlets as of March 2023. The company organizes its sales force by zones to ensure deep rural and urban penetration.
Strategic Growth
Expected Growth Rate
5-7%
Growth Strategy
Growth will be driven by the 'Power Brand' strategy (focusing on 9 key brands), expanding the distribution network, and a INR 500 Cr outlay for 'Dabur Ventures' to acquire digital-first brands. The merger with Sesa Care will expand the ayurvedic hair care portfolio, while the Badshah acquisition (51% for INR 587 Cr) drives entry into the branded spices market.
Products & Services
Chyawanprash, Honey, Honitus, Pudin Hara, Lal Tail, Real Juices, Amla Hair Oil, Red Toothpaste, Vatika Shampoo, Badshah Spices, and Sesa Ayurvedic Oil.
Brand Portfolio
Dabur, Vatika, Real, Hajmola, Pudin Hara, Honitus, Lal Tail, Dabur Red, Dabur Amla, Dabur Chyawanprash, Dabur Honey, Badshah, Sesa.
New Products/Services
Expansion into branded spices via Badshah Masala and premium ayurvedic hair oils via Sesa Care. Digital-first brands under Dabur Ventures are expected to contribute to future high-growth categories.
Market Expansion
Focus on South India via the new Tamil Nadu plant and increasing rural reach where demand is currently outperforming urban markets.
Market Share & Ranking
Maintains leading market positions in health supplements (Chyawanprash/Honey), digestives, and ayurvedic OTC categories.
Strategic Alliances
Joint Venture with Forum 1 Aviation (20% stake). Acquisition of 51% in Badshah Masala with a path to 100% in 5 years.
External Factors
Industry Trends
Shift toward herbal and natural products (growing at a faster rate than traditional FMCG). Dabur is positioned as a leader in this 'Ayurvedic' trend but faces increasing competition from MNCs launching 'natural' variants.
Competitive Landscape
Intense competition from organized players (MNCs like HUL, Nestle) and unorganized local players in the herbal segment.
Competitive Moat
Strong brand equity in Ayurveda (Dabur name) and a massive distribution moat of 7.7 million outlets. Sustainability is driven by the 'Power Brand' focus which ensures high marketing support for market-leading products.
Macro Economic Sensitivity
Highly sensitive to food inflation which subdues urban demand and GDP growth which influences rural consumption patterns.
Consumer Behavior
Increasing health consciousness is driving demand for immunity boosters (Chyawanprash) and natural personal care, though high inflation is causing temporary down-trading in urban areas.
Geopolitical Risks
Operations in Turkey, Egypt, and Nigeria expose the company to currency devaluation and political instability risks.
Regulatory & Governance
Industry Regulations
Subject to FSSAI standards for food and AYUSH regulations for ayurvedic products. Compliance with plastic waste management and workplace safety (zero fatalities reported).
Environmental Compliance
Maintains a board-level ESG committee; 50% of the board consists of independent directors.
Taxation Policy Impact
Effective September 22, 2025, 86% of Dabur's portfolio moved to the 5% GST category from 12% and 18%, which is expected to support volume growth.
Legal Contingencies
Pending GST demand of INR 320 Cr (challenged by the company). US litigation regarding hair relaxer products at Namaste Laboratories LLC (subsidiary); management claims the portfolio is <1% of revenue.
Risk Analysis
Key Uncertainties
Outcome of US hair relaxer litigation and the INR 320 Cr GST show-cause notice could impact cash flows. Potential for 10-15% impact on quarterly earnings if liabilities materialize.
Geographic Concentration Risk
Significant dependence on the North and West Indian markets, though expanding in South India via the Tamil Nadu plant.
Technology Obsolescence Risk
Risk of digital-first D2C brands disrupting traditional categories; mitigated by the INR 500 Cr Dabur Ventures fund.
Credit & Counterparty Risk
Superior liquidity with INR 6,604 Cr in cash and liquid investments as of Sept 2024 ensures low counterparty risk.